The Food and Drug Administration has approved two generic versions of an innovative drug to treat opioid addiction, increasing available treatment options for Americans fighting addiction. The move underscores a growing realization among policymakers, regulators and industry: to address the opioid crisis, innovative solutions must be readily available.
Thursday marked the White House Opioid Summit, which welcomed 200 affected Americans to discuss the crisis with Cabinet members. President Donald Trump declared the opioid abuse epidemic a public health emergency last fall.
The opioid abuse epidemic continues to generate state laws aimed at reducing opioid misuse and overdose.
A new plan to address chronic pain has garnered overwhelming support from patient advocates.
Following a lengthy and controversial process, the Centers for Disease Control and Prevention issued new guidelines Tuesday on prescribing opioids for pain.